Polypharmacy with oral antidiabetic agents: An indicator of poor glycemic control

American Journal of Managed Care

Volumn 12, Issue 8, 2006, Pages 435-440

  Willey, Cynthia J ^a,b   Andrade, Susan E ^a   Cohen, Joseph ^a   Fuller, Jackie C ^a   Gurwitz, Jerry H ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ALPHA GLUCOSIDASE INHIBITOR; GLYCOSYLATED HEMOGLOBIN; INSULIN; MEGLITINIDE; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

ADULT; AGED; ARTICLE; DATA BASE; FEMALE; GLYCEMIC CONTROL; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; POLYPHARMACY; PREDICTOR VARIABLE; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; HEALTH MAINTENANCE ORGANIZATIONS; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; NEW ENGLAND; POLYPHARMACY; RETROSPECTIVE STUDIES;

EID: 33747624202     PISSN: 10880224     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Boyle JP, Honeycutt AA, Narayan KM, et al. Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the US. Diabetes Care. 2001;24:1936-1940.
2. American Diabetes Association. Economic costs of diabetes in the US in 2002. Diabetes Care. 2003;26:917-932.
3. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications of insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
4. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837-853.
5. American Diabetes Association. Standards of medical care in diabetes. Diabetes Care. 2005;28(suppl 1):S4-S36.
6. Koro CE, Bowlin SJ, Bourgeois N, Fedder DO. Glycemic control from 1988 to 2000 among US adults diagnosed with type 2 diabetes: a preliminary report. Diabetes Care. 2004;27:17-20.
7. Karter AJ, Moffet HH, Liu J, et al. Achieving good glycemic control: initiation of new antihyperglycemic therapies in patients with type 2 diabetes from the Kaiser Permanente Northern California diabetes registry. Am J Manag Care. 2005;11:262-270.
8. Skyler JS, Oddo C. Diabetes trends in the USA. Diabetes Metab Res Rev. 2002;18(suppl 3):S21-S26.
9. Clark DO, Von Korff M, Saunders K, Baluch WM, Simon GE. A chronic disease score with empirically derived weights. Med Care. 1995;33:783-795.
10. Putnam KG, Buist DS, Fishman P, et al. Chronic disease score as a predictor of hospitalization. Epidemiology. 2002;13:340-346.
11. Cohen FJ, Neslusan CA, Conklin JE, Song X. Recent antihyperglycemic prescribing trends for US privately insured patients with type 2 diabetes. Diabetes Care. 2003;26:1847-1851.
12. Benoit SR, Fleming R, Philis-Tsimikas A, Ji M. Predictors of glycemic control among patients with type 2 diabetes: a longitudinal study. BMC Public Health. 2005;5:36.
13. Kogut SJ, Andrade SE, Willey C, Larrat EP. Nonadherence as a predictor of antidiabetic drug therapy intensification (augmentation). Pharmacoepidemiol Drug Saf. 2004;13:591-598.
14. Grant RW, Cagliero E, Dubey AK, et al. Clinical inertia in the management of type 2 diabetes metabolic risk factors. Diabetes Med. 2004;21:150-155.
15. Shah BR, Hux JE, Laupacis A, Zinman B, van Walreven C. Clinical inertia in response to inadequate glycemic control. Diabetes Care. 2005;28:600-606.
16. Wetzler HP, Snyder JW. Linking pharmacy and laboratory data to assess the appropriateness of care in patients with diabetes. Diabetes Care. 2000;23:1637-1641.
17. The stats on diabetes and drugs. Diabetes Forecast. January 1999;52:40.
18. Stafford RS, Davidson SM, Davidson H, Miracle-McMahill H, Crawford SL, Blumenthal D. Chronic disease medication use in managed care and indemnity insurance plans. Health Serv Res. 2003;38:595-612.